과제정보
This study is supported by the grants from the Jiangsu Provincial Medical Youth Talent (QNRC2016104, QNRC2016535) and the Science and Technology Support Program of Jiangsu Province (BE2018613).
참고문헌
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71: 209-249. https://doi.org/10.3322/caac.21660
- Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, et al. 2021. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Front. Public Health 8: 552028.
- Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. 2018. Best Pract. Res. Clin. Obstet. Gynaecol. 47: 14-26. https://doi.org/10.1016/j.bpobgyn.2017.08.006
- Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. 2019. Human Papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination-review of current perspectives. J. Oncol. 2019: 3257939.
- Boon SS, Luk HY, Xiao C, Chen Z, Chan PKS. 2022. Review of the standard and advanced screening, staging systems and treatment modalities for cervical cancer. Cancers (Basel) 14: 2913.
- Pogoda CS, Roden RB, Garcea RL. 2016. Immunizing against anogenital cancer: HPV vaccines. PLoS Pathog. 12: e1005587.
- Maver PJ, Poljak M. 2020. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans. Clin. Microbiol. Infect. 26: 579-583. https://doi.org/10.1016/j.cmi.2019.09.006
- Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. 2020. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle income countries. Lancet 395: 575-590. https://doi.org/10.1016/S0140-6736(20)30068-4
- Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. 2023. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob. Health 11: e197-e206.
- Bhatla N, Singhal S. 2020. Primary HPV screening for cervical cancer. Best Pract. Res. Clin. Obstet. Gynaecol. 65:98-108. https://doi.org/10.1016/j.bpobgyn.2020.02.008
- Catarino R, Petignat P, Dongui G, Vassilakos P. 2015. Cervical cancer screening in developing countries at a crossroad: emerging technologies and policy choices. World J. Clin. Oncol. 6: 281-290. https://doi.org/10.5306/wjco.v6.i6.281
- Chrysostomou AC, Stylianou DC, Constantinidou A, Kostrikis LG. 2018. Cervical cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing. Viruses 10: 729.
- Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, et al. 2012. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 30 Suppl 5: F88-99. https://doi.org/10.1016/j.vaccine.2012.06.095
- Laudadio J. 2013. Human papillomavirus detection: testing methodologies and their clinical utility in cervical cancer screening. Adv. Anat. Pathol. 20: 158-167. https://doi.org/10.1097/PAP.0b013e31828d1893
- Loopik DL, Koenjer LM, Siebers AG, Melchers WJG, Bekkers RLM. 2021. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program. Am. J. Obstet. Gynecol. 224: 200.e1-200.e9. https://doi.org/10.1016/j.ajog.2020.08.026
- Isidean SD, Coutlee F, Franco EL. 2014. Cobas 4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens. Expert Rev. Mol. Diagn. 14: 5-16. https://doi.org/10.1586/14737159.2014.865521
- Kashir J, Yaqinuddin A. 2020. Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19. Med. Hypotheses 141: 109786.
- Mu D, Zhou D, Xie G, Liu J, Xiong Q, Feng X, et al. 2021. The fluorescent probe-based recombinase-aided amplification for rapid detection of Escherichia coli O157:H7. Mol. Cell. Probes 60: 101777.
- Davi SD, Kissenkotter J, Faye M, Bohlken-Fascher S, Stahl-Hennig C, Faye O, et al. 2019. Recombinase polymerase amplification assay for rapid detection of Monkeypox virus. Diagn. Microbiol. Infect. Dis. 95: 41-45. https://doi.org/10.1016/j.diagmicrobio.2019.03.015
- Piepenburg O, Williams CH, Stemple DL, Armes NA. 2006. DNA detection using recombination proteins. PLoS Biol. 4: e204.
- Liu D, Zheng Y, Yang Y, Xu X, Kang H, Jiang Q, et al. 2022. Establishment and application of ERA-LFD method for rapid detection of feline calicivirus. Appl. Microbiol. Biotechnol. 106: 1651-1661. https://doi.org/10.1007/s00253-022-11785-6
- Zhang W, Xu L, Liu Q, Cao Y, Yang K, Song X, et al. 2021.Enzymatic recombinase amplification coupled with CRISPR-Cas12a for ultrasensitive, rapid, and specific Porcine circovirus 3 detection. Mol. Cell. Probes 60: 101772.
- Yang K, Liang Y, Li Y, Liu Q, Zhang W, Yin D, et al. 2021. Reverse transcription-enzymatic recombinase amplification coupled with CRISPR-Cas12a for rapid detection and differentiation of PEDV wild-type strains and attenuated vaccine strains. Anal. Bioanal. Chem. 413: 7521-7529. https://doi.org/10.1007/s00216-021-03716-7
- Li J, Wang Y, Hu J, Bao Z, Wang M. 2023. An isothermal enzymatic recombinase amplification (ERA) assay for rapid and accurate detection of Enterocytozoon hepatopenaei infection in shrimp. J. Invertebr. Pathol. 197: 107895.
- Xia S, Chen X. 2020. Single-copy sensitive, field-deployable, and simultaneous dual-gene detection of SARS-CoV-2 RNA via modified RT-RPA. Cell Discov. 6: 37.
- Ma W, Duan X, Tian Y, Jiao Z, Sun X, Zhao Z, et al. 2022. Recombinase polymerase amplification assay for sensitive and rapid detection of southern rice black-streaked dwarf virus in plants. J. Virol. Methods 301: 114467.
- Jang WS, Lim DH, Yoon J, Kim A, Lim M, Nam J, et al. 2021. Development of a multiplex Loop-Mediated Isothermal Amplification (LAMP) assay for on-site diagnosis of SARS CoV-2. PLoS One 16: e0248042.
- Wang J, Liu L, Wang J, Pang X, Yuan W. 2018. Real-time RPA assay for rapid detection and differentiation of wild-type pseudorabies and gE-deleted vaccine viruses. Anal. Biochem. 543: 122-127. https://doi.org/10.1016/j.ab.2017.12.012
- Wang X, Sui X, Ma Y, Li M, Zhang X, Fei D, et al. 2022. Real-time reverse transcription recombinase polymerase amplification for rapid detection of murine hepatitis virus. Front. Microbiol. 13: 1067694.
- Tian XX, Wang T, Cui XY, Huang XY, Sun Y, Xia DS, et al. 2022. Rapid visual detection of porcine reproductive and respiratory syndrome virus via recombinase polymerase amplification combined with a lateral flow dipstick. Arch. Virol. 167: 493-499. https://doi.org/10.1007/s00705-021-05349-8
- Zhou Y, Zheng HY, Jiang DM, Liu M, Zhang W, Yan JY. 2022. A rapid detection of tomato yellow leaf curl virus using recombinase polymerase amplification-lateral flow dipstick assay. Lett. Appl. Microbiol. 74: 640-646. https://doi.org/10.1111/lam.13611
- Lin H, Zhao S, Liu Y, Shao L, Ye Y, Jiang N, et al. 2022. Rapid visual detection of plasmodium using recombinase-aided amplification with lateral flow dipstick assay. Front. Cell. Infect. Microbiol. 12: 922146.
- Wang R, Pan W, Jin L, Huang W, Li Y, Wu D, et al. 2020. Human papillomavirus vaccine against cervical cancer: Opportunity and challenge. Cancer Lett. 471: 88-102. https://doi.org/10.1016/j.canlet.2019.11.039
- Bordigoni A, Motte A, Tissot-Dupont H, Colson P, Desnues C. 2021. Development and validation of a multiplex qPCR assay for detection and relative quantification of HPV16 and HPV18 E6 and E7 oncogenes. Sci. Rep. 11: 4039.
- Williams J, Kostiuk M, Biron VL. 2022. Molecular detection methods in HPV-related cancers. Front. Oncol. 12: 864820.
- Harari A, Chen Z, Burk RD. 2014. Human papillomavirus genomics: past, present and future. Curr. Probl. Dermatol. 45: 1-18. https://doi.org/10.1159/000355952
- Ma X, Li Y, Liu R, Wei W, Ding C. 2020. Development of a sensitive and specific nanoparticle-assisted PCR assay for detecting HPV-16 and HPV-18 DNA. J. Med. Virol. 12: 92.
- Chen Q, Yao L, Wu Q, Xu J, Yan C, Guo C, et al. 2022. Rapid and simultaneous visual typing of high-risk HPV-16/18 with use of integrated lateral flow strip platform. Mikrochim Acta 189: 350.
- Kumvongpin R, Jearanaikool P, Wilailuckana C, Sae-Ung N, Prasongdee P, Daduang S, et al. 2016. High sensitivity, loop-mediated isothermal amplification combined with colorimetric gold-nanoparticle probes for visual detection of high-risk human papillomavirus genotypes 16 and 18. J. Virol. Methods 234: 90-95. https://doi.org/10.1016/j.jviromet.2016.04.008
- Ma B, Fang J, Lin W, Yu X, Sun C, Zhang M. 2019. A simple and efficient method for potential point-of-care diagnosis of human papillomavirus genotypes: combination of isothermal recombinase polymerase amplification with lateral flow dipstick and reverse dot blot. Anal. Bioanal. Chem. 411: 7451-7460. https://doi.org/10.1007/s00216-019-02113-5
- Zheng X, Li Y, Yuan M, Shen Y, Chen S, Duan G. 2022. Rapid detection of HPV16/18 based on a CRISPR-Cas13a/Cas12a dual-channel system. Anal. Methods 14: 5065-5075. https://doi.org/10.1039/D2AY01536F
- He A, Fang C, Ming Y, Tan H, Zhang M, Zhang R, et al. 2022. Development of field-applicable endogenous internally controlled recombinase-aided amplification (EIC-RAA) assays for the detection of human papillomavirus genotypes 6 and 11 using sample releasing agent. Heliyon 8: e11323.
- Wang J, Liu J, Song G, Cao Z, Pan J, Li X, et al. 2020. Internally controlled recombinase-aided amplification (IC-RAA) assays for the detection of human papillomavirus genotypes 16 and 18 using extracted DNA and samples treated with nucleic acid releasing agent. Arch. Virol. 165: 2241-2247. https://doi.org/10.1007/s00705-020-04722-3